Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 410 participants.

Also called NCT02425371

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 410 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02425371
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02425371. Randomized; single masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2019-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years)
Acronym
OPTIMIZE-HFPEF
Condition
Heart Failure, Diastolic
Intervention (Other)
Screening and treatment of comorbidities
Intervention (Other)
Placebo Comparator
Lead sponsor
Göteborg University (class: other)
Collaborator
Umeå University (class: other)
Collaborator
Karolinska Institutet (class: other)
Collaborator
Uppsala University (class: other)
Collaborator
Vastra Gotaland Region (class: other government)

Record details

Record id
cardio:ct-nct02425371
Content hash
fd82b42ded9f54c142c28f40f5ee5ceabd0e501f7d49eda4abb84cb18775b903